Ami Organics Limited
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more
Ami Organics Limited (AMIORG) - Net Assets
Latest net assets as of March 2025: ₹13.20 Billion INR
Based on the latest financial reports, Ami Organics Limited (AMIORG) has net assets worth ₹13.20 Billion INR as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹15.49 Billion) and total liabilities (₹2.29 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹13.20 Billion |
| % of Total Assets | 85.21% |
| Annual Growth Rate | 54.82% |
| 5-Year Change | 690.78% |
| 10-Year Change | 4713.6% |
| Growth Volatility | 53.26 |
Ami Organics Limited - Net Assets Trend (2014–2025)
This chart illustrates how Ami Organics Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ami Organics Limited (2014–2025)
The table below shows the annual net assets of Ami Organics Limited from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹13.20 Billion | +93.35% |
| 2024-03-31 | ₹6.83 Billion | +14.95% |
| 2023-03-31 | ₹5.94 Billion | +13.73% |
| 2022-03-31 | ₹5.22 Billion | +212.86% |
| 2021-03-31 | ₹1.67 Billion | +49.30% |
| 2020-03-31 | ₹1.12 Billion | +36.00% |
| 2019-03-31 | ₹822.19 Million | +42.54% |
| 2018-03-31 | ₹576.82 Million | +47.93% |
| 2017-03-31 | ₹389.92 Million | +42.18% |
| 2016-03-31 | ₹274.24 Million | +84.91% |
| 2015-03-31 | ₹148.31 Million | +37.67% |
| 2014-03-31 | ₹107.73 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ami Organics Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₹409.35 Million | 3.13% |
| Other Comprehensive Income | ₹12.69 Billion | 96.87% |
| Total Equity | ₹13.10 Billion | 100.00% |
Ami Organics Limited Competitors by Market Cap
The table below lists competitors of Ami Organics Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SWEDISH LOGISTIC PROP. B
F:H45
|
$704.31 Million |
|
Gudeng Precision Industrial Co Ltd
TWO:3680
|
$704.52 Million |
|
Vestis Corporation
NYSE:VSTS
|
$705.34 Million |
|
Shangri-La Asia Limited
PINK:SHALF
|
$705.46 Million |
|
Sparekassen Sjaelland-Fyn A/S
CO:SPKSJF
|
$703.86 Million |
|
Jilin Liyuan Precision Manufacturing Co Ltd
SHE:002501
|
$703.83 Million |
|
Iperionx Ltd
AU:IPX
|
$703.27 Million |
|
Surgery Partners Inc
NASDAQ:SGRY
|
$703.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ami Organics Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,739,974,000 to 13,096,287,000, a change of 6,356,313,000 (94.3%).
- Net income of 1,587,136,000 contributed positively to equity growth.
- Dividend payments of 122,783,000 reduced retained earnings.
- New share issuances of 4,993,889,000 increased equity.
- Other comprehensive income increased equity by 12,643,878,000.
- Other factors decreased equity by 12,745,807,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹1.59 Billion | +12.12% |
| Dividends Paid | ₹122.78 Million | -0.94% |
| Share Issuances | ₹4.99 Billion | +38.13% |
| Other Comprehensive Income | ₹12.64 Billion | +96.55% |
| Other Changes | ₹-12.75 Billion | -97.32% |
| Total Change | ₹- | 94.31% |
Book Value vs Market Value Analysis
This analysis compares Ami Organics Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.12x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 345.00x to 8.12x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | ₹3.85 | ₹1327.40 | x |
| 2015-03-31 | ₹5.30 | ₹1327.40 | x |
| 2016-03-31 | ₹8.51 | ₹1327.40 | x |
| 2017-03-31 | ₹12.10 | ₹1327.40 | x |
| 2018-03-31 | ₹17.90 | ₹1327.40 | x |
| 2019-03-31 | ₹22.56 | ₹1327.40 | x |
| 2020-03-31 | ₹35.50 | ₹1327.40 | x |
| 2021-03-31 | ₹52.99 | ₹1327.40 | x |
| 2022-03-31 | ₹152.69 | ₹1327.40 | x |
| 2023-03-31 | ₹163.01 | ₹1327.40 | x |
| 2024-03-31 | ₹183.73 | ₹1327.40 | x |
| 2025-03-31 | ₹163.46 | ₹1327.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ami Organics Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.12%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.76%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 1.18x
- Recent ROE (12.12%) is below the historical average (24.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 26.58% | 3.77% | 1.96x | 3.59x | ₹17.87 Million |
| 2015 | 27.61% | 3.68% | 1.88x | 3.99x | ₹26.12 Million |
| 2016 | 46.15% | 8.28% | 1.65x | 3.37x | ₹99.14 Million |
| 2017 | 30.90% | 7.74% | 1.43x | 2.80x | ₹81.49 Million |
| 2018 | 32.06% | 10.08% | 1.18x | 2.70x | ₹127.27 Million |
| 2019 | 28.33% | 9.77% | 1.12x | 2.59x | ₹150.73 Million |
| 2020 | 24.57% | 11.46% | 1.03x | 2.07x | ₹162.89 Million |
| 2021 | 32.35% | 15.85% | 0.82x | 2.48x | ₹373.06 Million |
| 2022 | 13.78% | 13.88% | 0.79x | 1.26x | ₹197.19 Million |
| 2023 | 14.02% | 13.50% | 0.80x | 1.29x | ₹238.94 Million |
| 2024 | 6.35% | 5.96% | 0.65x | 1.63x | ₹-246.27 Million |
| 2025 | 12.12% | 15.76% | 0.65x | 1.18x | ₹277.51 Million |
Industry Comparison
This section compares Ami Organics Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,845,560,114
- Average return on equity (ROE) among peers: 14.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ami Organics Limited (AMIORG) | ₹13.20 Billion | 26.58% | 0.17x | $704.27 Million |
| Aarti Industries Limited (AARTIIND) | $8.75 Billion | 18.56% | 2.05x | $1.01 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $15.14 Million |
| ABM International Limited (ABMINTLLTD) | $214.51 Million | 3.09% | 0.89x | $294.24K |
| ACUTAAS CHEMICALS LTD (ACUTAAS) | $5.94 Billion | 14.02% | 0.29x | $247.08K |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $984.09 Million | 34.30% | 2.55x | $95.16 Million |
| Agarwal Industrial Corporation Limited (AGARIND) | $739.40 Million | 9.29% | 0.98x | $26.89 Million |
| Alkali Metals Limited (ALKALI) | $513.80 Million | 2.54% | 0.73x | $1.88 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $3.79 Billion | 22.71% | 1.01x | $204.91 Million |
| Anupam Rasayan India Limited (ANURAS) | $2.50 Billion | 13.94% | 1.53x | $318.75 Million |